| Serial Number | 79430127 |
| Word Mark | AIC |
| Filing Date | Thursday, July 10, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, June 16, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 16, 2026 |
| Goods and Services | Development of pharmaceutical preparations and medicines; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals; laboratory research in the field of pharmaceuticals; providing information technology services for the pharmaceutical and healthcare industries; providing medical research information in the field of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; conducting scientific research in the nature of clinical trials for pharmaceutical products for others; biological research, clinical surgery research and medical research; medical research laboratory services; scientific investigations for medical purposes |
| Description of Mark | The mark consists of the stylized letters "AIC" with the letter "I" in the middle forming part of both the "A" and the "C", and two additional circles above the letters "AIC". |
| Goods and Services | Medical services; pharmaceutical compounding services; medical screening; medical diagnostic services; consultancy and information services relating to biopharmaceutical products; consultancy and information services relating to medical products |
| Goods and Services | Pharmaceuticals in the nature of pharmaceutical preparations for the treatment of viral infections; diagnostic preparations and materials, for medical and veterinary purposes; antibiotics; antifungal medication; anti-viral agents; anti-cancer drugs; immunomodulators being pharmaceutical preparations for stimulating or suppressing the human immune system; cellular function activating agents for medical purposes;; blood substitutes for medical purposes; blood protein fractions for medical purposes; enzyme preparations for veterinary purposes; enzymes for veterinary purposes; enzyme preparations for medical purposes; greases for medical or veterinary purposes; vaccines; stem cells for veterinary purposes; stem cells for medical purposes; blood plasma |
| Goods and Services | Training services in the field of pharmaceutical and medical research and development; arranging and conducting of seminars in the field of pharmaceutical and medical research; teaching in the field of pharmacology; courses being training relating to science; publication of scientific information journals; non downloadable electronic publication in the nature of articles, brochures, abstracts and presentation slides in the field of pharmaceutical and medical research |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 14, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 14, 2025 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 14, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 14, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AiCuris Anti-infective Cures AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Party Name | AiCuris Anti-infective Cures AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
| Event Date | Event Description |
| Thursday, August 14, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, August 15, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 15, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, November 28, 2025 | ASSIGNED TO EXAMINER |
| Saturday, November 29, 2025 | NON-FINAL ACTION WRITTEN |
| Sunday, November 30, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, January 7, 2026 | REFUSAL PROCESSED BY MPU |
| Wednesday, January 7, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, January 22, 2026 | REFUSAL PROCESSED BY IB |
| Monday, April 27, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 27, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 27, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, May 16, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 27, 2026 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, May 27, 2026 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 10, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, June 11, 2026 | NOTIFICATION PROCESSED BY IB |
| Tuesday, June 16, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 16, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |